Tri Locum Partners »

United Therapeutics Corporation shares owned by Tri Locum Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 50k 318.55
2021-12-31 $9.9M 46k 216.08
2021-09-30 $6.1M 33k 184.59

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Argenx Se Sponsored Adr (ARGX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Amgen (AMGN)
Natera (NTRA)
Axsome Therapeutics (AXSM)
Insmed Com Par $.01 (INSM)
Merus N V (MRUS)
Regeneron Pharmaceuticals (REGN)
Madrigal Pharmaceuticals (MDGL)
Inspire Med Sys (INSP)
Avadel Pharmaceuticals Sponsored Adr
Pfizer (PFE)
United Therapeutics Corporation (UTHR)
Legend Biotech Corp Sponsored Ads (LEGN)

View all positions for Tri Locum Partners

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Citigroup
Geode Capital Management
FMR
LSV Asset Management
Morgan Stanley
AQR Capital Management
Dimensional Fund Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation